Free Reports

Middle East Alzheimer’s Disease Drugs Market Analysis Sample Report

Middle East Alzheimer’s Disease Drugs market was valued at $617 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $1267 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and government initiatives. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Johnson and Johnson, Lupin Limited, Biogen Inc, Pfizer Inc, F. Hoffmann-La Roche AG, Novartis AG, Allergan Plc (acquired by Abbvie), Amarantus Bioscience Holdings Inc, and GE Healthcare.